158 related articles for article (PubMed ID: 28123522)
21. A variant of estrogen receptor-alpha, ER-alpha36 is expressed in human gastric cancer and is highly correlated with lymph node metastasis.
Deng H; Huang X; Fan J; Wang L; Xia Q; Yang X; Wang Z; Liu L
Oncol Rep; 2010 Jul; 24(1):171-6. PubMed ID: 20514458
[TBL] [Abstract][Full Text] [Related]
22. Estrogen receptor α36 mediates a bone-sparing effect of 17β-estrodiol in postmenopausal women.
Xie H; Sun M; Liao XB; Yuan LQ; Sheng ZF; Meng JC; Wang D; Yu ZY; Zhang LY; Zhou HD; Luo XH; Li H; Wu XP; Wei QY; Tang SY; Wang ZY; Liao EY
J Bone Miner Res; 2011 Jan; 26(1):156-68. PubMed ID: 20578216
[TBL] [Abstract][Full Text] [Related]
23. ER-α36 mediates estrogen-stimulated MAPK/ERK activation and regulates migration, invasion, proliferation in cervical cancer cells.
Sun Q; Liang Y; Zhang T; Wang K; Yang X
Biochem Biophys Res Commun; 2017 Jun; 487(3):625-632. PubMed ID: 28435071
[TBL] [Abstract][Full Text] [Related]
24. Synuclein gamma stimulates membrane-initiated estrogen signaling by chaperoning estrogen receptor (ER)-alpha36, a variant of ER-alpha.
Shi YE; Chen Y; Dackour R; Potters L; Wang S; Ding Q; Wang Z; Liu YE
Am J Pathol; 2010 Aug; 177(2):964-73. PubMed ID: 20595634
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of ER-α36 expression sensitizes HER2 overexpressing breast cancer cells to tamoxifen.
Yin L; Pan X; Zhang XT; Guo YM; Wang ZY; Gong Y; Wang M
Am J Cancer Res; 2015; 5(2):530-44. PubMed ID: 25973295
[TBL] [Abstract][Full Text] [Related]
26. 17β-Estradiol inhibits testosterone-induced cell proliferation in HepG2 by modulating the relative ratios of 3 estrogen receptor isoforms to the androgen receptor.
Xu Z; Liu J; Jianxin C; Yongliang Z; Pan X
J Cell Biochem; 2018 Nov; 119(10):8659-8671. PubMed ID: 30058741
[TBL] [Abstract][Full Text] [Related]
27. Apoptotic action of 17beta-estradiol in raloxifene-resistant MCF-7 cells in vitro and in vivo.
Liu H; Lee ES; Gajdos C; Pearce ST; Chen B; Osipo C; Loweth J; McKian K; De Los Reyes A; Wing L; Jordan VC
J Natl Cancer Inst; 2003 Nov; 95(21):1586-97. PubMed ID: 14600091
[TBL] [Abstract][Full Text] [Related]
28. ER-α36 mediates cisplatin resistance in breast cancer cells through EGFR/HER-2/ERK signaling pathway.
Zhu L; Zou J; Zhao Y; Jiang X; Wang Y; Wang X; Chen B
J Exp Clin Cancer Res; 2018 Jun; 37(1):123. PubMed ID: 29940998
[TBL] [Abstract][Full Text] [Related]
29. Effects of 17β-estradiol and estrogen receptor antagonists on the proliferation of gastric cancer cell lines.
Kim MJ; Cho SI; Lee KO; Han HJ; Song TJ; Park SH
J Gastric Cancer; 2013 Sep; 13(3):172-8. PubMed ID: 24156037
[TBL] [Abstract][Full Text] [Related]
30. Involvement of ER-α36 in the malignant growth of gastric carcinoma cells is associated with GRP94 overexpression.
Fu Z; Deng H; Wang X; Yang X; Wang Z; Liu L
Histopathology; 2013 Sep; 63(3):325-33. PubMed ID: 23829397
[TBL] [Abstract][Full Text] [Related]
31. Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue.
Shen SS; Smith CL; Hsieh JT; Yu J; Kim IY; Jian W; Sonpavde G; Ayala GE; Younes M; Lerner SP
Cancer; 2006 Jun; 106(12):2610-6. PubMed ID: 16700038
[TBL] [Abstract][Full Text] [Related]
32. Quantitative profiles of the mRNAs of ER-alpha and its novel variant ER-alpha36 in breast cancers and matched normal tissues.
Zheng Y; Zhang J; Xu ZZ; Sheng JM; Zhang XC; Wang HH; Teng XD; Liu XJ; Cao J; Teng LS
J Zhejiang Univ Sci B; 2010 Feb; 11(2):144-50. PubMed ID: 20104649
[TBL] [Abstract][Full Text] [Related]
33. Estrogen receptor alpha-36 (ER-α36): A new player in human breast cancer.
Wang ZY; Yin L
Mol Cell Endocrinol; 2015 Dec; 418 Pt 3():193-206. PubMed ID: 25917453
[TBL] [Abstract][Full Text] [Related]
34. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
Zhang YX; Kong CZ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
[TBL] [Abstract][Full Text] [Related]
35. Estrogen receptor-α36-mediated rapid estrogen signaling regulates 78 kDa glucose-regulated protein expression in gastric carcinoma cells.
Fu Z; Wang X; Wang Z; Liu L
Oncol Lett; 2018 Jun; 15(6):10031-10036. PubMed ID: 29805694
[TBL] [Abstract][Full Text] [Related]
36. Crosstalk between estrogen receptor and mitogen-activated protein kinase signaling in the development and progression of endometrial cancer.
Zhou L; Cai B; Bao W; He YY; Chen XY; Yang YX; Liu XL; Wan XP
Int J Gynecol Cancer; 2011 Nov; 21(8):1357-65. PubMed ID: 21720253
[TBL] [Abstract][Full Text] [Related]
37. [The synergistic inhibitory effect of 5-aza-2-deoxycytidine and Tamoxifen on estrogen receptor alpha negative breast cancer cell lines in vitro].
Tang B; Peng ZH; Jiang J
Zhonghua Wai Ke Za Zhi; 2005 Dec; 43(23):1545-9. PubMed ID: 16412295
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the short-term biological effects of 7alpha-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)-nonyl]estra-1,3,5, (10)-triene-3,17beta-diol (Faslodex) versus tamoxifen in postmenopausal women with primary breast cancer.
Robertson JF; Nicholson RI; Bundred NJ; Anderson E; Rayter Z; Dowsett M; Fox JN; Gee JM; Webster A; Wakeling AE; Morris C; Dixon M
Cancer Res; 2001 Sep; 61(18):6739-46. PubMed ID: 11559545
[TBL] [Abstract][Full Text] [Related]
39. Differential effects of estradiol, raloxifene and tamoxifen on estrogen receptor expression in cultured human skin fibroblasts.
Haczynski J; Tarkowski R; Jarzabek K; Wolczynski S; Magoffin DA; Czarnocki KJ; Ziegert M; Jakowicki J; Jakimiuk AJ
Int J Mol Med; 2004 Jun; 13(6):903-8. PubMed ID: 15138633
[TBL] [Abstract][Full Text] [Related]
40. [Effect of gonadotropin-releasing hormone-I agonist and gonadotropin-releasing hormone-II on endometrial carcinoma cell lines with different states of PTEN].
Zhao LJ; Wei LH; Li XP; Wang JL
Zhonghua Fu Chan Ke Za Zhi; 2009 Jan; 44(1):45-9. PubMed ID: 19563062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
